关注
Vladimir E. Medvedev
Vladimir E. Medvedev
RUDN University (Российский университет дружбы народов)
在 rudn.ru 的电子邮件经过验证 - 首页
标题
引用次数
年份
22ndWorld Congress on Psychosomatic Medicine
VE Medvedev
Neurology, Neuropsychiatry, Psychosomatics 5 (4), 94-96, 2013
2013
A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders
VE Medvedev, ON Tereshchenko, I AIu, IK Chobanu, NV Kost, S OIu, ...
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 114 (7), 17-22, 2014
52014
Agomelatine (Valdoxan) in treatment of endogenous depression in day patient department
EV Chernova, OV Kozhechkina, AY Ter-Israelyan, VE Medvedev
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 116 (10), 43-46, 2016
52016
Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
VE Medvedev
Neuropsychiatric disease and treatment, 1141-1151, 2017
292017
Alimemazine in psychiatry and psychosomatics
VE Medvedev
Psikhiatriya i psikhofarmakoterapiya im. PB Gannushkina 20 (3-4), 26-33, 2018
62018
Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs
EA Ushkalova, SK Zyryanov, KE Zatolochina, AP Pereverzev, ...
Rational Pharmacotherapy in Cardiology 12 (4), 471-478, 2016
32016
Antidepressant therapy in patients with cardiovascular diseases
VE Medvedev, EA Korovyakova, VI Frolova, EV Gushanskaya
Neurology, Neuropsychiatry, Psychosomatics 11 (1), 131-140, 2019
92019
Anxiety and depression in COVID-19: treatment options
VE Medvedev
Neurology, Neuropsychiatry, Psychosomatics 13 (2), 111-116, 2021
102021
Assessment of the efficacy and tolerability of melatonergic antidepressant treatment in patients surgical correction of the appearance
VÉ Medvedev, TV Barsegian
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 114 (11 Pt 2), 3-9, 2014
2014
Astenic disorders within the framework of post-covid syndrome
VE Medvedev, VI Frolova, EV Gushanskaya, OV Kotova, NL Zuikova, ...
Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova 121 (4), 152-158, 2021
92021
Augmented antipsychotic therapy with pantogam active in patients with schizophrenia
VE Medvedev, VI Frolova, EV Gushanskaya, AU Ter-Israelyan
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 115 (8), 28-34, 2015
2015
Causeless appearance discontentment in patients of plastic surgeons and cosmetologists: Risk factors and patterns of dynamics
V Medvedev, V Frolova
European Psychiatry 41 (S1), s497-s497, 2017
12017
Clinical and psychosomatic peculiarities of essential hypertension under the conditions of chronic stress
K FIu, AL Syrkin, D MIu, SA Virusov, VE Medvedev
Klinicheskaia Meditsina 86 (2), 23-26, 2008
12008
Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome
OV Kotova, EV Tsareva, VE Medvedev, AA Belyaev, EV Gushanskaya, ...
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 122 (12), 39-44, 2022
2022
Combined therapy of neurasthenia in general medical practice
OR Dobrushina, VE Medvedev
Consilium Medicum 18 (2), 95-99, 2016
32016
Contemporary mental health care models and mental disorders treatment strategies
VE Medvedev, VI Frolova, RA Kardashyan
The Russian Archives of Internal Medicine, 73-78, 2015
22015
Correlations between doctors’ and patients’ assessment of depression’severity and efficacy of treatment
V Medvedev, K Retyunsky, A Ovchinnikov, Y Barilynik, A Shmilovich, ...
European Psychiatry 41 (S1), S534-S534, 2017
2017
COVID-19 and mental health: challenges and first conclusions
VE Medvedev, OA Dogotar
Neurology, neuropsychiatry, psychosomatics 12 (6), 4-10, 2020
222020
COVID-19 and mental health: Challenges and first conclusions [COVID-19 и психическое здоровье: вызовы и первые выводы]
V Medvedev, O Dogotar
2021
COVID-19 and stress-related disorders
OV Kotova, VE Medvedev, ES Akarachkova, AA Belyaev
Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 121 (5. Vyp. 2), 122-128, 2021
112021
系统目前无法执行此操作,请稍后再试。
文章 1–20